2 terminated. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Terminated 2 |
Follow Toxemia: new trials by email Literature Review of Toxemia trials Research Report on Toxemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Treatment of Septic Shock by Inhibiting Autodigestion and Preserving Gut Integrity With Enteric LB1148 LB1148, Placebo - Septic Shock | Phase 2 | Terminated | Leading BioSciences, Inc | 8 | 2015-04-01 | 2020-06-01 |
| CTI-01 (Ethyl Pyruvate) Safety and Complication Prevention in Cardiac Surgery Patients on Cardiopulmonary Bypass (CPB) CTI-01 (ethyl pyruvate) - Coronary Disease, Heart Valve Diseases | Phase 2 | Terminated | Critical Therapeutics | 150 | 2005-04-01 | 2006-03-17 |
Coronary Disease (1) · Endotoxemia (1) · Heart Valve Diseases (1) · Hyperlactatemia (1) · Infections (1) · Inflammation (1) · Multiple Organ Failure (1) · Sepsis (1) · Shock (1) · Shock, Septic (1) · Systemic Inflammatory Response Syndrome (1)
Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Bacteremia (1) · Cardiovascular Diseases (1) · Heart Diseases (1) · Infections (1) · Inflammation (1) · Metabolic Diseases (1) · Myocardial Ischemia (1) · Nutritional and Metabolic Diseases (1) · Sepsis (1) · Signs and Symptoms (1) · Systemic Inflammatory Response Syndrome (1) · Vascular Diseases (1)
Tranexamic Acid (1) · ethyl pyruvate (1)
Critical Therapeutics (1) · Leading BioSciences, Inc (1)
United States (2) · Canada (1)
Tom Hallam, PhD (1) · Walter Newman, Ph.D. (1)